Targeting bacterial RNA polymerase: promises for future antisense antibiotics development

Area of Science:

• Microbiology
• Structural Biology
• Drug Discovery

Background:

• DNA-dependent RNA polymerase (RNAP) is essential for bacterial transcription.
• Bacterial RNAP, unlike eukaryotic RNAP, is a viable target for antibacterial drug development.
• The σ factor is crucial for promoter recognition and transcription initiation.

Purpose of the Study:

• To review the assembly and function of bacterial RNAP subunits.
• To highlight structural insights into the σ factor.
• To discuss progress and challenges in targeting RNAP for antibacterial therapies.

Main Methods:

• Review of existing literature on bacterial RNAP structure and function.
• Analysis of structural data, particularly for the σ factor.
• Exploration of innovative strategies like antisense technology and phage-based screening.

Main Results:

• Bacterial RNAP is a promising target for novel antibacterial agents.
• Antisense technology and structural biology offer new avenues for RNAP inhibitor development.
• PNA-peptide conjugates targeting RNAP σ70 show broad-spectrum bactericidal effects in gram-negative bacteria.

Conclusions:

• Targeting bacterial RNAP, especially the σ70 factor, is a promising strategy for developing new antibiotics.
• Macro-molecule inhibitors, such as PNA-peptide conjugates, represent a new class of potential broad-spectrum antibacterial drugs.
• Antisense antibiotics hold significant potential for future healthcare applications.